TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
ODTX

Odyssey Therapeutics, Inc.

Healthcare · Biotechnology

22.20$ -1.0% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Cash Flow

Odyssey Therapeutics, Inc. (ODTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -129 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ODTX
Line item 2022 2023 2024 2025
-100 -113 -117 -129
2.8 4.9 5.2 4.9
5.5 6.3 8.7 14
-0.5 0.9 -3.3 -4.7
13 5.1 0.8 1.2
– – – -104
4.9 -4.8 – –
183 92 27 216
70 -186 6.3 -17
-113 -118 -118 -131

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?